Foghorn Therapeutics, Inc. (FHTX)
1.87
-0.04
(-1.84%)
USD |
NASDAQ |
Nov 06, 16:00
1.865
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Total Long Term Debt (Quarterly) : 40.28M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.28M |
| March 31, 2026 | 40.13M |
| December 31, 2025 | 40.35M |
| September 30, 2025 | 15.77M |
| June 30, 2025 | 17.52M |
| March 31, 2025 | 25.74M |
| December 31, 2024 | 28.06M |
| September 30, 2024 | 30.30M |
| June 30, 2024 | 32.54M |
| March 31, 2024 | 34.31M |
| December 31, 2023 | 36.56M |
| September 30, 2023 | 38.71M |
| June 30, 2023 | 40.27M |
| Date | Value |
|---|---|
| March 31, 2023 | 43.49M |
| December 31, 2022 | 45.54M |
| September 30, 2022 | 46.50M |
| June 30, 2022 | 49.14M |
| March 31, 2022 | 50.48M |
| December 31, 2021 | 51.34M |
| September 30, 2021 | 72.93M |
| June 30, 2021 | 74.93M |
| March 31, 2021 | 76.62M |
| December 31, 2020 | 78.02M |
| September 30, 2020 | 241.21M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 0.00 |
| Vaxcyte, Inc. | 215.14M |
| Connect Biopharma Holdings Ltd. | 0.203M |
| Caribou Biosciences, Inc. | 24.88M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |